REVB
Price
$2.81
Change
+$0.14 (+5.24%)
Updated
Apr 3 closing price
Capitalization
2.42M
TOVX
Price
$1.18
Change
-$0.00 (-0.00%)
Updated
Apr 3 closing price
Capitalization
3.28M
Ad is loading...

REVB vs TOVX

Header iconREVB vs TOVX Comparison
Open Charts REVB vs TOVXBanner chart's image
Revelation Biosciences
Price$2.81
Change+$0.14 (+5.24%)
Volume$39.8K
Capitalization2.42M
Theriva Biologics
Price$1.18
Change-$0.00 (-0.00%)
Volume$10.88K
Capitalization3.28M
REVB vs TOVX Comparison Chart
Loading...
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TOVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
REVB vs. TOVX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REVB is a Hold and TOVX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (REVB: $2.81 vs. TOVX: $1.18)
Brand notoriety: REVB and TOVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: REVB: 27% vs. TOVX: 16%
Market capitalization -- REVB: $2.42M vs. TOVX: $3.28M
REVB [@Biotechnology] is valued at $2.42M. TOVX’s [@Biotechnology] market capitalization is $3.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REVB’s FA Score shows that 2 FA rating(s) are green whileTOVX’s FA Score has 1 green FA rating(s).

  • REVB’s FA Score: 2 green, 3 red.
  • TOVX’s FA Score: 1 green, 4 red.
According to our system of comparison, REVB is a better buy in the long-term than TOVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REVB’s TA Score shows that 3 TA indicator(s) are bullish while TOVX’s TA Score has 6 bullish TA indicator(s).

  • REVB’s TA Score: 3 bullish, 2 bearish.
  • TOVX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, TOVX is a better buy in the short-term than REVB.

Price Growth

REVB (@Biotechnology) experienced а +1.81% price change this week, while TOVX (@Biotechnology) price change was -2.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

REVB is expected to report earnings on Mar 01, 2023.

TOVX is expected to report earnings on Nov 12, 2024.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TOVX($3.28M) has a higher market cap than REVB($2.42M). TOVX YTD gains are higher at: -32.571 vs. REVB (-61.903). REVB has higher annual earnings (EBITDA): -7.95M vs. TOVX (-19.29M). TOVX has more cash in the bank: 11.6M vs. REVB (6.5M). REVB has less debt than TOVX: REVB (0) vs TOVX (1.57M). REVB (0) and TOVX (0) have equivalent revenues.
REVBTOVXREVB / TOVX
Capitalization2.42M3.28M74%
EBITDA-7.95M-19.29M41%
Gain YTD-61.903-32.571190%
P/E RatioN/AN/A-
Revenue00-
Total Cash6.5M11.6M56%
Total Debt01.57M-
FUNDAMENTALS RATINGS
TOVX: Fundamental Ratings
TOVX
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
REVBTOVX
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
57%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
REVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TOVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DUO0.300.02
+6.18%
Fangdd Network Group Ltd
CLBT18.77-1.06
-5.35%
Cellebrite DI Ltd
COYA6.10-0.44
-6.73%
Coya Therapeutics
MRNA25.73-1.99
-7.18%
Moderna
KE13.71-2.30
-14.37%
Kimball Electronics

REVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, REVB has been loosely correlated with GNPX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if REVB jumps, then GNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REVB
1D Price
Change %
REVB100%
+5.24%
GNPX - REVB
48%
Loosely correlated
+46.31%
TCRT - REVB
46%
Loosely correlated
+50.71%
CRIS - REVB
35%
Loosely correlated
-10.14%
TOVX - REVB
31%
Poorly correlated
N/A
TSHA - REVB
31%
Poorly correlated
-4.55%
More

TOVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TOVX has been loosely correlated with GOVX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if TOVX jumps, then GOVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TOVX
1D Price
Change %
TOVX100%
N/A
GOVX - TOVX
54%
Loosely correlated
-6.78%
TNXP - TOVX
35%
Loosely correlated
+0.58%
SER - TOVX
34%
Loosely correlated
+1.86%
REVB - TOVX
31%
Poorly correlated
+5.24%
GENFF - TOVX
25%
Poorly correlated
-40.40%
More